Related Experiment Video
Updated: Apr 28, 2026

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
A case study of modeling and exposure-response prediction for count data.
Hui Quan1, Xuezhou Mao, Lynn Wei
1a Biostatistics and Programming, Sanofi, Bridgewater , New Jersey , USA.
Determining the optimal drug dose can be challenging. Modeling plasma concentration data helps predict treatment effects for unstudied doses, aiding final dose selection in clinical trials.
Area of Science:
- Pharmacometrics
- Clinical Trial Design
- Biostatistics
Background:
- Selecting the final commercial drug dose can be difficult even after Phase III studies.
- Traditional methods may not fully leverage available plasma concentration data for dose optimization.
Purpose of the Study:
- To illustrate a modeling approach for predicting treatment effects at various plasma concentrations.
- To demonstrate how this approach can justify final dose selection in Phase III clinical trials.
Main Methods:
- Utilizing plasma concentration data from Phase III studies.
- Applying pharmacokinetic-pharmacodynamic (PK/PD) modeling to link concentration and effect.
- Comparing statistical models including overdispersed Poisson, negative binomial, and recurrent event models.
Main Results:
- The negative binomial model demonstrated superior data fitting.
- The chosen model allowed for within-treatment and between-treatment comparisons.
- The modeling approach successfully predicted treatment effects for unstudied doses.
Conclusions:
- Modeling plasma concentration data is a valuable tool for dose confirmation.
- The negative binomial model is recommended for count data in similar scenarios.
- This method supports evidence-based final dose selection in drug development.
More Related Videos
Related Concept Videos
Mechanistic Models: Compartment Models in Individual and Population Analysis
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Odds Ratio
Dose-Response Relationship: Overview
Statistical Methods for Analyzing Epidemiological Data

